Half-year report · Q2
2503.TEDINET S100WHH8
Period2025-01-01 → 2025-06-30
Filed2025-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.14T | 2025-01-01 → 2025-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.34T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.10T | 2024-01-01 → 2024-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥68.7bn | 2025-01-01 → 2025-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥80.9bn | 2024-01-01 → 2024-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥83.8bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥139.7bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥108.5bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥52.8bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥58.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥57.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥60.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥74.2bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥3.30T | at 2025-06-30 | Cons. | Assets IFRS |
| Total assets | ¥3.35T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥3.13T | at 2024-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.89T | at 2025-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.82T | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.41T | at 2025-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.53T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.59T | at 2024-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.43T | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.12T | at 2025-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.18T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.29T | at 2024-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥132.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥138.4bn | at 2024-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥131.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥67.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥242.8bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥108.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥61.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥329.4bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥116.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥35.8bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥58.1bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥21.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥65.23 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥71.87 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥65.22 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥71.86 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥70.65 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 34.0% | at 2025-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 35.2% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 41.2% | at 2024-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥47.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥14.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥32.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | −¥591m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥38.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥38.3bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥30.0bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥493.8bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥492.6bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥53.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥129.7bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥127.2bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥273.4bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥271.8bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥29.5bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥230.7bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥230.5bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥156m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥33.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-06-30 | ¥45.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥34.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-06-30 | −¥331m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥38.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥26.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥513.7bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥512.5bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥50.3bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥71.1bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥69.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.6bn |
| jpcrp040300-q2r_E00395-000Health Sciencereportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.6bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥271.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥270.0bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥30.1bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥233.0bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥232.8bn |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥132m |
| jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥41.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 858
| Item | Context | Value | Unit |
|---|---|---|---|
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember | 41070000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember | -1592000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -331000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_ReconcilingItemsMember | -26524000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration | 93069000000 | JPY |
| Other operating income IFRS | Prior1YTDDuration | 4402000000 | JPY |
| Other operating expenses IFRS | Prior1YTDDuration | 16581000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 11719000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 4369000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | 20301000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 108541000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember | 492628000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember | 271805000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember | 230498000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember | 127247000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 14132000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration | 1136309000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember | 1159000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember | 1598000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember | 156000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember | 2489000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 32889000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -38291000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration | － | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember | 493787000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember | 273403000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember | 230654000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember | 129736000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 47021000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -38291000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 1136309000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000AlcoholicBeveragesReportableSegmentMember | 53162000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000NonAlcoholicBeveragesReportableSegmentMember | 29537000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000PharmaceuticalsReportableSegmentMember | 33503000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00395-000HealthScienceReportableSegmentMember | 8615000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -591000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | -29981000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration | 94245000000 | JPY |
| Other operating income IFRS | CurrentYTDDuration | 2135000000 | JPY |
| Other operating expenses IFRS | CurrentYTDDuration | 27658000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 4644000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 8998000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | 19392000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 83761000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-08-08 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第187期中(自 2025年１月１日 至 2025年６月30日) |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |